Aprea Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Doylestown, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Aprea Therapeutics, Inc. has filed 437 SEC EDGAR filings since 12 Jul 2019

SEC filing history

Showing 376-400 of 437 matching filings.

Per page
25
Current page
16
SC 13G File 005-91159

SC 13G

Filing date
17 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91159

SC 13D

Filing date
17 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91159

SC 13D

Filing date
17 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91159

SCHEDULE 13G HOLDINGS REPORT

Filing date
11 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91159

SCHEDULE 13G

Filing date
09 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
08 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39069

8-K

Filing date
07 Oct 2019
Reporting date
07 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-233662

424B4

Filing date
04 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-233662

FWP

Filing date
03 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-233662

EFFECT filing

Filing date
02 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .